USA. Harm Reduction Therapeutics to Receive Additional Funding for the Development of its Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma after Bankruptcy Court Approval
USA. Harm Reduction Therapeutics to Receive Additional Funding for the Development of its Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma after Bankruptcy Court Approval
Harm Reduction Therapeutics (HRT) will receive up to $11 million of additional financial support from Purdue Pharma L.P. to advance its development of a low-cost, over-the-counter (OTC) naloxone nasal spray in the United States. Naloxone is an opioid antagonist rescue medication used to reverse the effects of a life-threatening opioid overdose. (bakersfield.com, USA, 23.03.2022)
https://www.bakersfield.com/ap/news/harm-reduction-therapeutics-to-receive-additional-funding-for-the-development-of-its-over-the-counter/article_c67acbbd-4598-5630-86ca-ecc5e108a9e8.html